NCT01347060 Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy Status COMPLETED Phase N/A
NCT01346852 Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients Status COMPLETED Phase N/A
NCT01345916 Efficacy of CHF1535 Via NEXT DPI Versus pMDI and BDP DPI100µg on PeakExpiratoryFlow in Asthmatic Patients Status COMPLETED Phase PHASE3
NCT01345396 Influence of an Asthma Education Programme on Asthma Control During Pregnancy Status SUSPENDED Phase NA
NCT01343407 A Two-part Study of the Effects of MK-1029 in Allergen-Challenged Asthmatics (MK-1029-003) Status COMPLETED Phase PHASE1
NCT01340209 Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma Status COMPLETED Phase PHASE3
NCT01340118 Improvement of FeNO and FEF25-75 After Inhaled Corticosteroid Treatment of Asthma Status COMPLETED Phase PHASE4
NCT01334853 A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma Status COMPLETED Phase N/A
NCT01333800 Cost-effectiveness Study of Beclomethasone Versus Ciclesonide as Controller Medications in Pediatric Asthma Status COMPLETED Phase PHASE4
NCT01332422 Special Drug Use Investigation for ADOAIR Metered-dose Inhaler (Pediatric) Status COMPLETED Phase N/A
NCT01332357 Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit Status COMPLETED Phase N/A
NCT01332344 Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids Status COMPLETED Phase N/A
NCT01332292 Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic Patients Status COMPLETED Phase PHASE2
NCT01329939 The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic Asthmatics Status COMPLETED Phase NA
NCT01328964 Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population Status COMPLETED Phase N/A
NCT01327001 Utilization of Fixed Combination (Budesonide/Formoterol and Salmeterol/Fluticasone and Beclomethasone/Formoterol) in Treatment of Asthma Patients Status COMPLETED Phase N/A
NCT01326494 Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia Status COMPLETED Phase PHASE4